Type to search

Bioscience and pharmaceutical Commercial Real Estate Economic Development Insider Only New Castle County News Public Companies

Prelude Therapeutics signs CRISP lease for future HQ

Avatar photo
Share

WILMINGTON – Cancer treatment research company Prelude Therapeutics has signed a major lease for its future headquarters at the Chestnut Run Innovation and Science Park (CRISP), the first new tenant at the former DuPont research and development campus recently acquired by MRA Group. On Nov. 30, Prelude entered into a lease agreement for 81,000 square

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2024 Delaware Business Times

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Limited time offer. New subscribers only.

SUMMER FLASH SALE!

Subscribe to Delaware Business Times and save 50%